Clin2
NCT07427017Possibly a fitRecruiting

Selenium for Ulcerative Colitis Patients on Biologics

Ulcerative Colitis (UC)

Part of Digestive system clinical trials.

This trial tests whether taking selenium supplements can help people with moderate to severe ulcerative colitis that is being treated with advanced therapies (biologics). The goal is to see if selenium can improve symptoms and reduce inflammation.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
180 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You have moderate to severe ulcerative colitis.
  • You are starting or switching to a biologic (like Remicade, Stelara, or Entyvio).
  • You are between 18 and 85 years old.
  • You are not pregnant or planning pregnancy during the study.
  • You do not have kidney disease, diabetes, or thyroid problems.
  • You are not taking blood thinners, certain antibiotics, or other drugs that may interact with selenium.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07758335Recruiting· Phase 4
Probiotics and trace elements for ulcerative colitis

This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.

Cairo
NCT07650942Not yet recruiting· Phase 3
Study drug for moderate to severe ulcerative colitis

This trial tests an oral study drug called Hemay005 for people with moderate to severe ulcerative colitis (UC) who have not responded well to other treatments. If you join, you will receive either the study drug or a placebo (inactive pill) to see if it helps reduce symptoms and heal the gut lining.

Guangzhou
NCT07742410Not yet recruiting
Stool tests and colonoscopy for ulcerative colitis monitoring

This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.

NCT07619638Not yet recruiting
Microbiome Supplement for Mild-to-Moderate Ulcerative Colitis

This trial tests a specially designed supplement that aims to restore healthy gut bacteria in people with mild-to-moderate ulcerative colitis. The goal is to reduce inflammation and improve symptoms like rectal bleeding and bowel urgency.

Izmir
NCT07411131Not yet recruiting
Synbiotic supplement for mild ulcerative colitis

This study tests a new food supplement (a synbiotic, which combines good bacteria and food for them) to see if it helps control symptoms of ulcerative colitis, a type of inflammatory bowel disease. If you have mild to moderate ulcerative colitis, this supplement might help reduce inflammation and improve your gut health.

Hong Kong
NCT07857447Not yet recruiting
Mediterranean diet for ulcerative colitis

This study tests whether a modified Mediterranean diet can help people with mild to moderate ulcerative colitis. It may reduce inflammation and improve symptoms.

Zagreb

Hear when a new Ulcerative Colitis (UC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.